تعداد نشریات | 20 |
تعداد شمارهها | 1,149 |
تعداد مقالات | 10,518 |
تعداد مشاهده مقاله | 45,415,694 |
تعداد دریافت فایل اصل مقاله | 11,291,483 |
Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea | ||
Iranian Journal of Medical Sciences | ||
مقاله 8، دوره 39، شماره 1، فروردین 2014، صفحه 60-63 اصل مقاله (210.94 K) | ||
نوع مقاله: Brief Report(s) | ||
نویسندگان | ||
Omid Reza Zekavat* 1؛ Ali Reza Makarem2؛ Sezaneh Haghpanah1؛ Zohreh Karamizadeh3؛ Parvin Javad1؛ Mehran Karimi1 | ||
1Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran | ||
2Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran | ||
3Department of Pediatric Endocrinology, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran | ||
چکیده | ||
Hydroxyurea (HU) has been successfully used in patients with β-thalassemia intermedia (β-TI). We aimed to evaluate the effect of the long-term use of HU on thyroid function in patients with β-TI. Seventy-five patients with β-TI aged≥11 years and taking HU were randomly selected during 2010 in southern Iran. Thirty-one patients with β-TI without HU were considered as a control group. Serum levels of thyroid stimulating hormone (TSH) and T4 were measured. The mean age of the participants was 22.7±5.1 years (age range=12-41 years). Serum ferritin level had no significant correlation with HU consumption (P>0.05). Overall, we detected 10 (9.4%) patients with hypothyroidism. We found that the use of HU at a dose of 8-15 mg/kg/day has no significant association with thyroid function in β-TI patients. However, due to the small sample size in our study, documentation of this finding needs further studies with higher numbers of patients. | ||
کلیدواژهها | ||
Thalassemia intermedia؛ Hydroxyurea؛ Thyroid function | ||
آمار تعداد مشاهده مقاله: 3,129 تعداد دریافت فایل اصل مقاله: 1,254 |